NCT01440998
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +34 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Endometrial Neoplasms
Explore clinical trials studying Endometrial Neoplasms. Study availability and eligibility vary by location and protocol.
19 public trials
4 recruiting studies
Endometrial Neoplasms trial results
NCT01210222
- Conditions
- Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, +21 more
- Locations
-
- Hartford Hospital Hartford, Connecticut, United States
- The Hospital of Central Connecticut New Britain, Connecticut, United States
- Sarasota Memorial Hospital Sarasota, Florida, United States
- Memorial University Medical Center Savannah, Georgia, United States
NCT02150213
- Conditions
- Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, +23 more
- Locations
-
- Novartis Investigative Site Tallahassee, Florida, United States
- Novartis Investigative Site Baltimore, Maryland, United States
- Novartis Investigative Site Hoffman, New Jersey, United States
- Novartis Investigative Site Dallas, Texas, United States
Completed
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
NCT00154388
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +121 more
- Locations
-
Not specified
NCT00897442
- Conditions
- Adenoma, Adnexal Diseases, Borderline Ovarian Clear Cell Tumor, +143 more
- Locations
-
- Highlands Oncology Group PA - Fayetteville Fayetteville, Arkansas, United States
- Washington Regional Medical Center - Fayetteville Fayetteville, Arkansas, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
NCT03660826
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +28 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
Active, Not Recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013
- Conditions
- Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
Active, Not Recruiting
Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.
NCT02598219
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +20 more
- Locations
-
- Polyclinique Urbain V Avignon, France
- Centre Hospitalier Régional Universitaire Besançon, France
- Institut Bergonié Bordeaux, France
- Centre Jean Perrin Clermont-Ferrand, France
Active, Not Recruiting
Phase I Trial of Defactinib and VS-6766.
NCT03875820
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +27 more
- Locations
-
- The Christie NHS Foundation Trust Manchester, Greater Manchester, United Kingdom
- The Royal Marsden NHS Foundation Trust Sutton, Surrey, United Kingdom
- The Royal Marsden NHS Foundation Trust - Gynecology Unit London, United Kingdom
- The Newcastle Upon Tyne Hospitals NHS Foundation Trust - Freeman Hospital Newcastle, United Kingdom